📣 VC round data is live. Check it out!
- Public Comps
- RTW Biotech Opportunities
RTW Biotech Opportunities Valuation Multiples
Discover revenue and EBITDA valuation multiples for RTW Biotech Opportunities and similar public comparables like Noah Holdings, Wereldhave Belgium, Vinci Partners, Mogan Enerji and more.
RTW Biotech Opportunities Overview
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Its approach is driven by applying deep scientific expertise with a long-term investment horizon. Geographically, it operates in U.S. &Canada, UK & EU, and Rest of the world.
Founded
2017
HQ

Employees
0
Website
Sectors
Financials (FY)
EV
$706M
Valuation Multiples
Start free trialRTW Biotech Opportunities Financials
RTW Biotech Opportunities reported last fiscal year revenue of $251M.
In the same fiscal year, RTW Biotech Opportunities generated $245M in net income.
RTW Biotech Opportunities P&L
In the most recent fiscal year, RTW Biotech Opportunities reported revenue of $251M and net income of $245M.
RTW Biotech Opportunities is profitable as of last fiscal year, with net margin of 98%.
Financial data powered by Morningstar, Inc.
RTW Biotech Opportunities Stock Performance
RTW Biotech Opportunities has current market cap of $706M, and enterprise value of $706M.
Market Cap Evolution
RTW Biotech Opportunities' stock price is $2.18.
RTW Biotech Opportunities share price increased by 1.4% in the last 30 days, and by 90.4% in the last year.
RTW Biotech Opportunities has an EPS (earnings per share) of $0.76.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $706M | $706M | 0.9% | 1.4% | 4.3% | 90.4% | $0.76 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRTW Biotech Opportunities Valuation Multiples
RTW Biotech Opportunities trades at 2.8x EV/Revenue multiple.
RTW Biotech Opportunities Financial Valuation Multiples
As of May 9, 2026, RTW Biotech Opportunities has market cap of $706M and EV of $706M.
RTW Biotech Opportunities has a P/E ratio of 2.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified RTW Biotech Opportunities Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


RTW Biotech Opportunities Margins & Growth Rates
In the most recent fiscal year, RTW Biotech Opportunities reported net margin of 98%.
RTW Biotech Opportunities Margins
RTW Biotech Opportunities Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
RTW Biotech Opportunities Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
RTW Biotech Opportunities Competitors
RTW Biotech Opportunities competitors include Noah Holdings, Wereldhave Belgium, Vinci Partners, Mogan Enerji, Qualitas Real Estate, Investment AB Oresund, TINC, Thornburg Inc Builder, Platinum Capital and Regal Partners.
Most RTW Biotech Opportunities public comparables operate across Asset Management and PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| (0.0x) | (0.0x) | (0.1x) | (0.1x) | |||
| 10.0x | 13.5x | 15.8x | — | |||
| 2.9x | 2.8x | 7.2x | 9.3x | |||
| 5.7x | — | 14.5x | — | |||
| — | 11.4x | — | 13.8x | |||
| 7.5x | — | — | — | |||
| 10.5x | 9.9x | 15.9x | 14.4x | |||
| 6.7x | — | — | — | |||
This data is available for Pro users. Sign up to see all RTW Biotech Opportunities competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout RTW Biotech Opportunities
| When was RTW Biotech Opportunities founded? | RTW Biotech Opportunities was founded in 2017. |
| Where is RTW Biotech Opportunities headquartered? | RTW Biotech Opportunities is headquartered in United Kingdom. |
| How many employees does RTW Biotech Opportunities have? | As of today, RTW Biotech Opportunities has over 0 employees. |
| Is RTW Biotech Opportunities publicly listed? | Yes, RTW Biotech Opportunities is a public company listed on London Stock Exchange. |
| What is the stock symbol of RTW Biotech Opportunities? | RTW Biotech Opportunities trades under RTW ticker. |
| Who are competitors of RTW Biotech Opportunities? | RTW Biotech Opportunities main competitors include Noah Holdings, Wereldhave Belgium, Vinci Partners, Mogan Enerji, Qualitas Real Estate, Investment AB Oresund, TINC, Thornburg Inc Builder, Platinum Capital, Regal Partners. |
| What is the current market cap of RTW Biotech Opportunities? | RTW Biotech Opportunities' current market cap is $706M. |
| What is the current revenue of RTW Biotech Opportunities? | RTW Biotech Opportunities' last fiscal year revenue is $251M. |
| What is the current EV/Revenue multiple of RTW Biotech Opportunities? | Current revenue multiple of RTW Biotech Opportunities is 2.8x. |
| Is RTW Biotech Opportunities profitable? | No, RTW Biotech Opportunities is not profitable. |
| How many companies RTW Biotech Opportunities has acquired to date? | RTW Biotech Opportunities hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies RTW Biotech Opportunities has invested to date? | RTW Biotech Opportunities hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to RTW Biotech Opportunities
Lists including RTW Biotech Opportunities
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.